Snowden Capital Advisors LLC Novo Cure LTD Transaction History

Snowden Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$63.98 - $85.37 $12,923 - $17,244	202 Added 6.08%	3,524 $258,000
Q3 2022 Nov 09, 2022	BUY	$67.99 - $89.57 $225,862 - $297,551	3,322 New	3,322 $252,000
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $541 - $760	-9 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $675 - $1,097	9 New	9 $0

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.